BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24129397)

  • 1. Sestrin 3 regulation in type 2 diabetic patients and its influence on metabolism and differentiation in skeletal muscle.
    Nascimento EB; Osler ME; Zierath JR
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1408-14. PubMed ID: 24129397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of skeletal muscle sucrose, non-fermenting 1/AMP-activated protein kinase-related kinase (SNARK) by metabolic stress and diabetes.
    Rune A; Osler ME; Fritz T; Zierath JR
    Diabetologia; 2009 Oct; 52(10):2182-9. PubMed ID: 19652946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
    Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
    Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
    Mashili F; Chibalin AV; Krook A; Zierath JR
    Diabetes; 2013 Feb; 62(2):457-65. PubMed ID: 23043161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAK tyrosine phosphorylation is regulated by AMPK and controls metabolism in human skeletal muscle.
    Lassiter DG; Nylén C; Sjögren RJO; Chibalin AV; Wallberg-Henriksson H; Näslund E; Krook A; Zierath JR
    Diabetologia; 2018 Feb; 61(2):424-432. PubMed ID: 29022062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle.
    Al-Khalili L; Bouzakri K; Glund S; Lönnqvist F; Koistinen HA; Krook A
    Mol Endocrinol; 2006 Dec; 20(12):3364-75. PubMed ID: 16945991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes.
    Al-Khalili L; de Castro Barbosa T; Ostling J; Massart J; Cuesta PG; Osler ME; Katayama M; Nyström AC; Oscarsson J; Zierath JR
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C774-87. PubMed ID: 25143351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle.
    Austin RL; Rune A; Bouzakri K; Zierath JR; Krook A
    Diabetes; 2008 Aug; 57(8):2066-73. PubMed ID: 18443205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus.
    Kulkarni SS; Salehzadeh F; Fritz T; Zierath JR; Krook A; Osler ME
    Metabolism; 2012 Feb; 61(2):175-85. PubMed ID: 21816445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance.
    Kurucz I; Morva A; Vaag A; Eriksson KF; Huang X; Groop L; Koranyi L
    Diabetes; 2002 Apr; 51(4):1102-9. PubMed ID: 11916932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
    Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
    Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
    Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired enhancement of insulin action in cultured skeletal muscle cells from insulin resistant type 2 diabetic patients in response to contraction using electrical pulse stimulation.
    Al-Bayati A; Brown A; Walker M
    J Diabetes Complications; 2019 Dec; 33(12):107412. PubMed ID: 31575461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced incorporation of fatty acids into triacylglycerol in myotubes from obese individuals with type 2 diabetes.
    Sparks LM; Bosma M; Brouwers B; van de Weijer T; Bilet L; Schaart G; Moonen-Kornips E; Eichmann TO; Lass A; Hesselink MKC; Schrauwen P
    Diabetes; 2014 May; 63(5):1583-1593. PubMed ID: 24487026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?
    Gillberg L; Jacobsen SC; Ribel-Madsen R; Gjesing AP; Boesgaard TW; Ling C; Pedersen O; Hansen T; Vaag A
    PLoS One; 2013; 8(3):e58384. PubMed ID: 23505498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-Related Ankyrin Repeat Protein (DARP/Ankrd23) Modifies Glucose Homeostasis by Modulating AMPK Activity in Skeletal Muscle.
    Shimoda Y; Matsuo K; Kitamura Y; Ono K; Ueyama T; Matoba S; Yamada H; Wu T; Chen J; Emoto N; Ikeda K
    PLoS One; 2015; 10(9):e0138624. PubMed ID: 26398569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men.
    Mäkinen S; Sree S; Ala-Nisula T; Kultalahti H; Koivunen P; Koistinen HA
    Diabetologia; 2024 May; ():. PubMed ID: 38814443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perilipin 3 Differentially Regulates Skeletal Muscle Lipid Oxidation in Active, Sedentary, and Type 2 Diabetic Males.
    Covington JD; Noland RC; Hebert RC; Masinter BS; Smith SR; Rustan AC; Ravussin E; Bajpeyi S
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3683-92. PubMed ID: 26171795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
    Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
    Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary defects in lipid handling and resistance to exercise in myotubes from obese donors with and without type 2 diabetes.
    Løvsletten NG; Rustan AC; Laurens C; Thoresen GH; Moro C; Nikolić N
    Appl Physiol Nutr Metab; 2020 Feb; 45(2):169-179. PubMed ID: 31276628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.